Ngā hua rapu - Filip Moerman
- E whakaatu ana i te 1 - 2 hua o te 2
-
1
HIV‐1 Immune Suppression and Antimalarial Treatment Outcome in Zambian Adults with Uncomplicated Malaria mā Jean‐Pierre Van Geertruyden, Modest Mulenga, Lawrence Mwananyanda, Victor Chalwe, Filip Moerman, Roma Chilengi, Webster Kasongo, Chantal Van Overmeir, Jean‐Claude Dujardin, Robert Colebunders, Luc Kestens, Umberto D’Alessandro
I whakaputaina 2006Artigo -
2
Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial mā Jozefien Declercq, Karel Van Damme, Elisabeth De Leeuw, Bastiaan Maes, Cédric Bosteels, Simon J. Tavernier, Stefanie De Buyser, Roos Colman, Maya Hites, Gil Verschelden, Tom Fivez, Filip Moerman, Ingel Demedts, Nicolás Dauby, Nicolas De Schryver, Elke Govaerts, Stefaan J. Vandecasteele, Johan Van Laethem, Sébastien Anguille, Jeroen C.H. van der Hilst, Benoît Misset, Hans Slabbynck, Xavier Wittebole, F Liénart, Catherine Legrand, Marc Buyse, Dieter Stevens, F Bauters, Leen Seys, Helena Aegerter, Ursula Smole, Victor Bosteels, Levi Hoste, Leslie Naesens, Filomeen Haerynck, Linos Vandekerckhove, Pieter Depuydt, Eva Van Braeckel, Sylvie Rottey, Isabelle Peene, Catherine Van Der Straeten, Frank Hulstaert, Bart N. Lambrecht
I whakaputaina 2021Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Immunology
Internal medicine
Medicine
Virology
2019-20 coronavirus outbreak
Betacoronavirus
Clinical trial
Confidence interval
Coronavirus disease 2019 (COVID-19)
Cytokine
Cytokine release syndrome
Disease
Infectious disease (medical specialty)
Interleukin
Interleukin 6
Malaria
Outbreak
Parasitemia
Pharmacology
Plasmodium falciparum
Randomized controlled trial
Relative risk
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)